Contact Us
UBC Insights

Insights from
UBC's Expert Voices

Featured Updates

Featured Image
Blog
June 11, 2025 4 min read

Linking real-world data with commercial patient access programs: A strategy for enhanced insights into factors that impact patient access and adherence to therapy
UBC’s approach to real-world data tokenization and linkage enhances study results with longitudinal observation of various participant health outcomes during the pre-and post-trial period.
Samuel Igweokpala
Associate Epidemiologist at UBC
People discussing using glass whiteboard and post-it notes
Blog
April 28, 2025 8 min read

Longitudinal Real-World Data: How to Gain Deeper Insights Into Your Clinical Studies
Linking longitudinal real-world data (RWD) to clinical study data offers deeper insights for drug developers. Contextualize study outcomes, extend data collection after the study ends, close the efficacy-effectiveness gap, and identify post-market patterns.
Featured Image
Blog
April 15, 2025 7 min read

Evolving PV Landscape: Artificial Intelligence and Advanced Gene Therapy
UBC Pharmacovigilance experts, Dobrochna Dolicka, Christopher Henry, Alix Garcia and Irene Navarro presented at DIA Europe 2025 on how AI can be used to streamline pharmacovigilance activities and how harmonization of guidelines can be enhanced in order to define a specific framework for gene therapy.

Posts by Date

Featured Image
Blog
June 11, 2025 4 min read

Linking real-world data with commercial patient access programs: A strategy for enhanced insights into factors that impact patient access and adherence to therapy
UBC’s approach to real-world data tokenization and linkage enhances study results with longitudinal observation of various participant health outcomes during the pre-and post-trial period.
Samuel Igweokpala
Associate Epidemiologist at UBC
People discussing using glass whiteboard and post-it notes
Blog
April 28, 2025 8 min read

Longitudinal Real-World Data: How to Gain Deeper Insights Into Your Clinical Studies
Linking longitudinal real-world data (RWD) to clinical study data offers deeper insights for drug developers. Contextualize study outcomes, extend data collection after the study ends, close the efficacy-effectiveness gap, and identify post-market patterns.
Featured Image
Blog
April 15, 2025 7 min read

Evolving PV Landscape: Artificial Intelligence and Advanced Gene Therapy
UBC Pharmacovigilance experts, Dobrochna Dolicka, Christopher Henry, Alix Garcia and Irene Navarro presented at DIA Europe 2025 on how AI can be used to streamline pharmacovigilance activities and how harmonization of guidelines can be enhanced in order to define a specific framework for gene therapy.
Featured Image
Blog
April 4, 2025 16 min read

Unlocking the Potential of Psychedelic Therapies
Psychedelic-assisted therapies are starting to emerge with potential as treatments for mental health conditions. Explore the evidence behind an increased interest in this use of substances such as psilocybin, MDMA, LSD, and DMT, and the future of research in this area.
Catherine Miller, MSN, CRNP, FNP-BC
Senior Project Manager, Safety, Epidemiology, Registries and Risk Management
Featured Image
Blog
March 4, 2025 6 min read

The Crucial Role of Adherence Support for Patients Prescribed a High-Cost Injectable or Infusion Therapy
Adherence is critical to ensuring patients receive full therapeutic benefit and effectively manage their disease, particularly for complex treatments such as injectables or infusions. Explore strategies to support patients and improve adherence in the blog.
Marci Gott
Executive Director, Patient Services
An Asian businesswoman writing on a whiteboard uring conference meeting
Blog
February 4, 2025 17 min read

Global Risk Management and Risk Evaluation and Mitigation Strategy (REMS) Developments in 2024 and Considerations for 2025
Dive deep on a number of developments occurred during 2024 that will drive considerations in risk management and REMS for 2025 and beyond.
Featured Image
Blog
December 4, 2024 7 min read

Driving Program Awareness through Stakeholder Collaboration
This article explores strategies to enhance Patient Service Programs (PSPs) awareness through digital engagement and provider collaboration.
Featured Image
Blog
November 11, 2024 4 min read

Standardization and the Evolving REMS Landscape
Learn about the FDA's new guidance, the challenges of standardization, and how UBC is driving innovation in REMS implementation using modern APIs from UBC's VP of Data Intelligence and Program Analytics, Jim Shamp.
Featured Image
Blog
November 1, 2024 4 min read

The Evolution of Patient Support for Cell and Gene Therapy Products
Discover UBC's insights from the Cell & Gene Meeting on the Mesa, the unique challenges patients face, and the importance of tailored support services to ensure successful treatment journeys
1 2 3 … 15

Press Inquires

Want to know more about us?

Subscribe Now

Want to know more about us?

Subscribe Now

About us

Solutions

Insights

Resources

For HCPs

Clinical

Contact us

About UBC

Other

Evidence Development

Safety & Risk Management

Patient Access

Providers

Technology Solutions

ubc-logo-footer
©2025 United BioSource LLC, all rights reserved
UBC®, CLÆRITY®, SæfetyWorks®, ExpressConnect® and UBC Pathways® are trademarks of United BioSource LLC.
Twitter Linkedin
UBC logo white

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

  • Leverage automation to move fast
  • Always give customers a human to chat to
  • Automate customer support and close leads faster
Return to Homepage
Connect with Us on LinkedIn
UBC logo white

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown Headshot

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.